Patents by Inventor Angela Aguslyarti SALIM

Angela Aguslyarti SALIM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS AND USE THEREOF IN METHODS OF TREATMENT
    Publication number: 20240002326
    Abstract: Disclosed are compounds of a formula provided herein that show efficacy in the inhibition of SOX18 protein activity, and in particular with respect to the ability of SOX18 to bind DNA and/or particular protein partners. Further, methods of treating angiogenesis- and/or lymphangiogenesis-related diseases, disorders or conditions, such as cancer metastasis and vascular cancers, are provided herein.
    Type: Application
    Filed: June 27, 2023
    Publication date: January 4, 2024
    Inventors: Mathias FRANCOIS, Johannes ZUEGG, Jeroen OVERMAN, Sreeman Kumar MAMIDYALA, Angela Aguslyarti SALIM, Frank Roger FONTAINE, Matthew Allister COOPER, Robert John CAPON, Avril Alexis Barbara ROBERTSON
  • INHIBITORS OF SOX18 PROTEIN ACTIVITY FOR TREATING ANGIOGENESIS AND/OR LYMPHANGIOGENESIS-RELATED DISEASES
    Publication number: 20230100768
    Abstract: Disclosed are compounds of a formula provided herein that show efficacy in the inhibition of SOX18 protein activity, and in particular with respect to the ability of SOX18 to bind DNA and/or particular protein partners. Further, methods of treating angiogenesis- and/or lymphangiogenesis-related diseases, disorders or conditions, such as cancer metastasis and vascular cancers, are provided herein.
    Type: Application
    Filed: May 10, 2022
    Publication date: March 30, 2023
    Inventors: Mathias FRANCOIS, Johannes ZUEGG, Jeroen OVERMAN, Sreeman Kumar MAMIDYALA, Angela Aguslyarti SALIM, Frank Roger FONTAINE, Matthew Allister COOPER, Robert John CAPON, Avril Alexis Barbara ROBERTSON
  • Inhibitors of SOX18 protein activity for treating angiogenesis-and/or lymphangiogenesis-related diseases
    Patent number: 11434190
    Abstract: Disclosed are compounds of a formula provided herein that show efficacy in the inhibition of SOX18 protein activity, and in particular with respect to the ability of SOX18 to bind DNA and/or particular protein partners. Further, methods of treating angiogenesis- and/or lymphangiogenesis-related diseases, disorders or conditions, such as cancer metastasis and vascular cancers, are provided herein.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: September 6, 2022
    Assignee: THE UNIVERSITY OF QUEENSLAND
    Inventors: Mathias Francois, Johannes Zuegg, Jeroen Overman, Sreeman Kumar Mamidyala, Angela Aguslyarti Salim, Frank Roger Fontaine, Matthew Allister Cooper, Robert John Capon, Avril Alexis Barbara Robertson
  • INHIBITORS OF SOX18 PROTEIN ACTIVITY FOR TREATING ANGIOGENESIS-AND/OR LYMPHANGIOGENESIS-RELATED DISEASES
    Publication number: 20190337880
    Abstract: Disclosed are compounds of a formula provided herein that show efficacy in the inhibition of SOX18 protein activity, and in particular with respect to the ability of SOX18 to bind DNA and/or particular protein partners. Further, methods of treating angiogenesis- and/or lymphangiogenesis-related diseases, disorders or conditions, such as cancer metastasis and vascular cancers, are provided herein.
    Type: Application
    Filed: December 21, 2017
    Publication date: November 7, 2019
    Inventors: Mathias FRANCOIS, Johannes ZUEGG, Jeroen OVERMAN, Sreeman Kumar MAMIDYALA, Angela Aguslyarti SALIM, Frank Roger FONTAINE, Matthew Allister COOPER, Robert John CAPON, Avril Alexis Barbara ROBERTSON